SHANGHAI and SAN DIEGO, June 2, 2022 /PRNewswire/ — Neurophth Therapeutics, Inc., (hereinafter referred to as “Neurophth”) today announced the appointment of Xiaoning Guo, Ph.D., as the Chief Medical Officer (CMO). Dr. Xiaoning Guo will have overall responsibility for the drug…
News Ticker
- [ June 5, 2023 ] Staff Research Associate II – UC San Diego Health – San Diego, CA San Diego Biotech Jobs
- [ June 5, 2023 ] Supervisor, Laboratory – Bio-techne – San Marcos, CA San Diego Biotech Jobs
- [ June 5, 2023 ] UC San Diego Health Recognized for Leadership in Environmental Sustainability News
- [ June 5, 2023 ] Cali Biosciences Initiates Second Phase III Study of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use and Presents Consistent and Predictable PK Results Across Multiple Surgeries News
- [ June 5, 2023 ] Wounded Warrior Project to Team Up with VA to Empower Veterans at Adaptive Sports Clinic News
Copyright © 2023 Biotech Networks, LLC
